|

Decision making in the therapeutic jungle of aHCC: a Changing Treatment Dynamic

Expert guidance on systemic aHCC treatment choices tailored to your patient's needs.

 

PROGRAMME:

  • HCC landscape and new data
  • Certainties & uncertainties in HCC
  • Case 1: NASH (elderly, frail patient)
  • Case 2: AtezoBev followed by second line
  • Case 3: Transplant patient
  • Closing: Glimpse of the future

Modules:

Instructors

Prof. Dr. Ivan Borbath

Prof. Dr. Ivan Borbath

UCL, Brussels

Prof. Dr. Chris Verslype

Prof. Dr. Chris Verslype

UZ Leuven, chair

Modules: